BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25312474)

  • 21. Oral fluid testing as an alternative to urine testing for drugs of abuse in inpatient forensic settings: giving patients choice.
    MacCall CA; Ritchie G; Sood M
    Scott Med J; 2013 May; 58(2):99-103. PubMed ID: 23728755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of psychoactive substances, alcohol, illicit drugs, and medicines, in Spanish drivers: a roadside study.
    Gómez-Talegón T; Fierro I; González-Luque JC; Colás M; López-Rivadulla M; Javier Álvarez F
    Forensic Sci Int; 2012 Nov; 223(1-3):106-13. PubMed ID: 22947432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of anonymous pooled urine from portable urinals in central London confirms the significant use of novel psychoactive substances.
    Archer JR; Dargan PI; Hudson S; Wood DM
    QJM; 2013 Feb; 106(2):147-52. PubMed ID: 23178933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analytical techniques for drug detection in oral fluid.
    Lillsunde P
    Ther Drug Monit; 2008 Apr; 30(2):181-7. PubMed ID: 18367978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a urine on-site drugs of abuse screening test in patients admitted to a psychiatric emergency unit.
    Bagøien G; Morken G; Zahlsen K; Aamo T; Spigset O
    J Clin Psychopharmacol; 2009 Jun; 29(3):248-54. PubMed ID: 19440078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent substance intake among patients admitted to acute psychiatric wards: physician's assessment and on-site urine testing compared with comprehensive laboratory analyses.
    Mordal J; Holm B; Mørland J; Bramness JG
    J Clin Psychopharmacol; 2010 Aug; 30(4):455-9. PubMed ID: 20631563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drugs of abuse testing in a psychiatric outpatient service.
    Shearer DS; Baciewicz GJ; Kwong TC
    Clin Lab Med; 1998 Dec; 18(4):713-26. PubMed ID: 9891610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations.
    Thekedar B; Oeh U; Szymczak W; Hoeschen C; Paretzke HG
    J Breath Res; 2011 Mar; 5(1):016001. PubMed ID: 21383425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A field test of substance use screening devices as part of routine drunk-driving spot detection operating procedures in South Africa.
    Matzopoulos R; Lasarow A; Bowman B
    Accid Anal Prev; 2013 Oct; 59():118-24. PubMed ID: 23770390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydrogen cyanide concentrations in the breath of adult cystic fibrosis patients with and without Pseudomonas aeruginosa infection.
    Gilchrist FJ; Bright-Thomas RJ; Jones AM; Smith D; Spaněl P; Webb AK; Lenney W
    J Breath Res; 2013 Jun; 7(2):026010. PubMed ID: 23680696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of abused drugs in human exhaled breath using mass spectrometry: A review.
    Zhang J; Zhang Y; Xu C; Huang Z; Hu B
    Rapid Commun Mass Spectrom; 2023 Sep; 37 Suppl 1():e9503. PubMed ID: 36914281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug testing in the workplace.
    Phan HM; Yoshizuka K; Murry DJ; Perry PJ
    Pharmacotherapy; 2012 Jul; 32(7):649-56. PubMed ID: 22605533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection times of drugs of abuse in blood, urine, and oral fluid.
    Verstraete AG
    Ther Drug Monit; 2004 Apr; 26(2):200-5. PubMed ID: 15228165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Background levels and diurnal variations of hydrogen cyanide in breath and emitted from skin.
    Schmidt FM; Metsälä M; Vaittinen O; Halonen L
    J Breath Res; 2011 Dec; 5(4):046004. PubMed ID: 21808098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does oral fluid contribute to exhaled breath samples collected by means of an electret membrane?
    Garzinsky AM; Walpurgis K; Krug O; Thevis M
    Drug Test Anal; 2019 Nov; 11(11-12):1764-1770. PubMed ID: 30927335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Illicit drug use in the pain patient population decreases with continued drug testing.
    Pesce A; West C; Rosenthal M; Mikel C; West R; Crews B; Almazan P; Latyshev S; Horn PS
    Pain Physician; 2011; 14(2):189-93. PubMed ID: 21412373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization and validation of CEDIA drugs of abuse immunoassay tests in serum and urine on an Olympus AU 400.
    Musshoff F; Wolters T; Lott S; Ippisch J; Gradl S; Madea B
    Drug Test Anal; 2013 May; 5(5):366-71. PubMed ID: 23386567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measuring substance use in the club setting: a feasibility study using biochemical markers.
    Gripenberg-Abdon J; Elgán TH; Wallin E; Shaafati M; Beck O; Andréasson S
    Subst Abuse Treat Prev Policy; 2012 Feb; 7():7. PubMed ID: 22321198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. False-positive cannabis results in Italian workplace drug testing.
    Fucci N; De Giovanni N
    Drug Test Anal; 2012 Feb; 4(2):71-3. PubMed ID: 22362572
    [No Abstract]   [Full Text] [Related]  

  • 40. Drugs of abuse in oral fluid collected by two different sample kits--stability testing and validation using ultra performance tandem mass spectrometry analysis.
    Lund HM; Øiestad EL; Gjerde H; Christophersen AS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3367-77. PubMed ID: 21962269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.